Jazz Pharmaceuticals, Inc. to Announce Third Quarter Financial Results on November 13, 2008

PALO ALTO, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. today announced that it will report third quarter 2008 financial results on November 13, 2008, before the open of U.S. financial markets. Jazz Pharmaceuticals will host an investor conference call and live audio webcast to discuss the results and company updates on November 13, 2008, at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time.

The live webcast and press release may be accessed on Jazz Pharmaceuticals' website at http://www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast. An archived version of the webcast will be available through November 27, 2008.

Investors may participate in the conference call by dialing 866-825-3308 in the U.S., or 617-213-8062 outside the U.S., and entering passcode 82730571. A replay of this call will be available until November 27, 2008 at 888-286-8010 or 617-801-6888 (international), using the passcode 10707678.

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at http://www.earnings.com and institutional investors can access the call via http://www.streetevents.com.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company identifying, developing and commercializing innovative treatments for important, underserved markets in neurology and psychiatry. For further information, please visit http://www.jazzpharmaceuticals.com.

CONTACT: Karen L. Bergman, +1-650-575-1509, or Michelle Corral,
+1-415-794-8662, both of BCC Partners for Jazz Pharmaceuticals, Inc.; or
Matthew Fust, Chief Financial Officer of Jazz Pharmaceuticals, Inc.,
+1-650-496-2800, investorinfo@jazzpharmaceuticals.com

Web site: http://www.jazzpharmaceuticals.com/

Back to news